BRIEF-Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results

Reuters
Dec 02, 2025
BRIEF-Chemomab <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Nebokitug Phase 2 Spring Trial Results

Dec 2 (Reuters) - Chemomab Therapeutics Ltd CMMB.O:

  • CHEMOMAB THERAPEUTICS ANNOUNCES NEBOKITUG PHASE 2 SPRING TRIAL RESULTS IN PRIMARY SCLEROSING CHOLANGITIS PUBLISHED IN THE AMERICAN JOURNAL OF GASTROENTEROLOGY

Source text: ID:nGNX9D7CG9

Further company coverage: CMMB.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10